BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alsebaey A, Elhelbawy M, Waked I. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease. Eur J Gastroenterol Hepatol. 2018;30:207-211. [PMID: 29240565 DOI: 10.1097/meg.0000000000001013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Michalak A, Cichoż-Lach H, Guz M, Kozicka J, Cybulski M, Jeleniewicz W, Stepulak A. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales. World J Gastroenterol 2020; 26(47): 7538-7549 [PMID: 33384553 DOI: 10.3748/wjg.v26.i47.7538] [Reference Citation Analysis]
2 Catanzaro R, Sciuto M, Lanzafame C, Balakrishnan B, Marotta F. Platelet to lymphocyte ratio as a predictive biomarker of liver fibrosis (on elastography) in patients with hepatitis C virus (HCV)-related liver disease. Indian J Gastroenterol 2020;39:253-60. [PMID: 32833144 DOI: 10.1007/s12664-020-01038-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sanchez-Autet M, Arranz B, Sierra P, Safont G, Garcia-Blanco A, de la Fuente L, Garriga M, Marín L, García-Portilla MP. Association between Neutrophil-Lymphocyte ratio, Platelet-Lymphocyte ratio, and C-Reactive Protein levels and metabolic status in patients with a bipolar disorder. World J Biol Psychiatry 2021;:1-27. [PMID: 34856870 DOI: 10.1080/15622975.2021.2013089] [Reference Citation Analysis]
4 Hanberg JS, Freiberg MS, Goetz MB, Rodriguez-Barradas MC, Gibert C, Oursler KA, Justice AC, Tate JP; VACS Project Team. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and HIV/HCV Coinfection. Open Forum Infect Dis 2019;6:ofz347. [PMID: 31660334 DOI: 10.1093/ofid/ofz347] [Reference Citation Analysis]
5 Fayed HM, Mahmoud HS, Elaiw Mohamed Ali A. The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals. Clin Exp Gastroenterol 2020;13:53-63. [PMID: 32110084 DOI: 10.2147/CEG.S229689] [Reference Citation Analysis]
6 Yuan X, Duan SZ, Cao J, Gao N, Xu J, Zhang L. Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients. Eur J Gastroenterol Hepatol 2019;31:1467-74. [PMID: 31107735 DOI: 10.1097/MEG.0000000000001437] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
7 Cengiz M, Ozenirler S. Serum Peptidyl-prolyl Cis-trans Isomerase NIMA-interacted 1 (Pin1) as a Non-invasive Marker for Liver Fibrosis due to Chronic Hepatitis C Virus. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.116687] [Reference Citation Analysis]
8 Greenberg JW, Kim J, Pincus J, Sandberg ML, Dick B, Greenberg RM, Raheem O, Hellstrom WJ. Are neutrophil–lymphocyte and platelet–lymphocyte ratios useful for determining active phase of Peyronie’s disease? Journal of Clinical Urology. [DOI: 10.1177/20514158221094636] [Reference Citation Analysis]
9 Ekin N, Ucmak F, Ebik B, Tugba Tuncel E, Kacmaz H, Arpa M, Engin Atay A. GPR, King's Score and S-Index are superior to other non-invasive fibrosis markers in predicting the liver fibrosis in chronic Hepatitis B patients. Acta Gastroenterol Belg 2022;85:62-8. [PMID: 35304995 DOI: 10.51821/85.1.9156] [Reference Citation Analysis]